Asymmetric Hydrogenation of Triazolo[1,5-<i>a</i>]-, Imidazo[1,2-<i>a</i>]-, and Pyrazolo[1,5-<i>a</i>]pyridines
The asymmetric hydrogenation of a series of triazolo[1,5-<i>a</i>]-, imidazo[1,2-<i>a</i>]-, and pyrazolo[1,5-<i>a</i>]pyridines, which have received little coverage in the literature, was investigated. The hydrogenation was achieved in high yields and moderate to good enantioselectivities using Ru precatalysts and bis(naphthylethyl)-substituted NHC ligands (SINpEt). Several new ligands of the SINpEt family were developed, which proved crucial for an enantioselective transformation. Particularly, an alkoxy group at the C2 position of the 1-naphthyl group led to a considerably higher selectivity. Remarkably, hydrogenation at room temperature with H<sub>2</sub> pressures as low as 5 bar could be achieved.
Authors
- Philip J. Pye
- Matthieu Jouffroy (ORCID: https://orcid.org/0000-0003-4478-2502)
- Wouter Herrebout (ORCID: https://orcid.org/0000-0002-3167-8944)
- Matthew A. Horwitz (ORCID: https://orcid.org/0000-0003-3934-9317)
- Carlo Sambiagio (ORCID: https://orcid.org/0000-0001-8536-103X)
- Kangying Li (ORCID: https://orcid.org/0000-0001-9432-8012)
- José Manuel Bartolomé-Nebreda
- Bert U. W. Maes (ORCID: https://orcid.org/0000-0003-0431-7606)
- Dirk Lauwers (ORCID: https://orcid.org/0000-0002-3362-4616)
- Guido Verniest
Institutions
- Johnson & Johnson (United States) (US)
- Janssen (Belgium) (BE)
- University of Antwerp (BE)
- Johnson & Johnson (United Kingdom) (GB)
Publication Details
- Journal
- Organic Letters
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1021/acs.orglett.5c03318
- Citations
- 1
- Primary Topic
- Asymmetric Hydrogenation and Catalysis
- Type
- article
- Field-Weighted Citation Impact
- 0.54